A comparative effectiveness analysis of single-agent cytotoxics in triple-negative metastatic breast cancer (TN-MBC) patients.
George Dranitsaris
Consultant or Advisory Role - Eisai
Research Funding - Eisai
Hope S. Rugo
Consultant or Advisory Role - Eisai
Stefan Gluck
Consultant or Advisory Role - Eisai
David Cox
Employment or Leadership Position - Eisai
Claudio Faria
Employment or Leadership Position - Eisai